“life-sciences” Archives

in
Entry Author Date Location
For $140M, PTC Gets Duchenne Drug and a Pricing Controversy from Marathon 03/16/17 New York
Proteon Therapeutics Plans Path Forward for Blood Vessel Drug 03/16/17 Boston
With FDA’s Blessing, Seres Preps New “Pivotal” Microbiome Drug Trial 03/16/17 Boston
CRISPR Organs? eGenesis Raises $38M For Pig-To-Human Transplants 03/16/17 Boston
Myomo, a Robotic Arm Brace Maker, Aims to Raise $15M in “Mini-IPO” 03/15/17 Boston
Former Gates Investor, Advisor Unveil $200M Biomatics Health Fund 03/15/17 Seattle
Human Longevity Offers Genome Sequencing Through MassMutual 03/15/17 San Diego
Invenra Adds Partners, Still Open to Developing Own Drugs in Future 03/14/17 Wisconsin
First Trial in Sight, Editas Cuts $90M Eye Drug Deal With Allergan 03/14/17 Boston
Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed? 03/13/17 National
WARF, Cellectar Expand Licensing Agreement For Blood Cancer Drug 03/10/17 Wisconsin
Scott Gottlieb On Tap to Lead FDA, and Biopharma Exhales 03/10/17 National
Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain Cancer 03/10/17 San Diego
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More 03/10/17 National
BioAffinity Secures $150K Investment from San Antonio-Run Biz Group 03/09/17 Texas
Biotech With Drug Developed by San Antonio Researcher Explores Sale 03/09/17 Texas
Larry Smarr Drives Innovation as Experimental Patient of the Future 03/09/17 San Diego
Houston’s Biotech Innovation Community Reacts to Robbins Exit at TMC 03/08/17 Texas
Backed by $37M, Virta Tries Tech Approach to “Reverse” Diabetes 03/08/17 San Francisco
DePinho Announces His Departure from Houston’s MD Anderson 03/08/17 Texas
TMC CEO Robbins To Leave, Take Top University of Arizona Post 03/08/17 Texas
Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics 03/08/17 Boston
Biotech Vet Dunsire’s New Challenge: Grow Tiny Startup, XTuit 03/08/17 Boston
CureMatch Uses Analytics to Rank Best Options for Cancer Treatment 03/07/17 San Diego
Bluegrass Vascular Gets Funding, Signs Distribution Deal With Merit 03/06/17 Texas
Seattle Genetics to Resume Leukemia Drug Trials After FDA Lifts Hold 03/06/17 Seattle
Vertex Bags Concert’s Rival CF Drug For $160M, Plans Combo Studies 03/06/17 Boston
How Boragen Banked $10M to Develop New Boron-Based Fungicides 03/06/17 Raleigh Durham
Ingeneron Gets $20M From Sanford Health For Stem Cell Treatment 03/06/17 Texas
VenBio-Backed Directors Wrest Control of Immunomedics Board 03/03/17 New York
Page 4 of 320 « previous page · next page »